A significant advance in cancer study is emerging with the use of mini-antibodies to restore dysfunctional p53. This vital tumor suppressor protein is frequently inactivated in many forms of malignancies, causing https://businessbookmark.com/story7559460/nanobodies-reactivate-p53-new-potential-approach-for-malignant-therapy